SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-17-055511
Filing Date
2017-09-05
Accepted
2017-09-05 17:09:42
Documents
4
Group Members
NOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-21327_1sc13g.htm SC 13G 95850
2 GRAPHIC g213271bei001.gif GRAPHIC 130323
3 GRAPHIC g213271bei002.gif GRAPHIC 136094
4 GRAPHIC g213271bei003.gif GRAPHIC 50454
  Complete submission text file 0001104659-17-055511.txt   534087
Mailing Address 2910 SEVENTH ST BERKELEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Subject) CIK: 0000791908 (see all company filings)

IRS No.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38028 | Film No.: 171069480
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations